LensGen is a startup based in the United States, most recent round Series B, 3 tracked investors.
Based in the United States, LensGen is a startup. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
LensGen is an ophthalmic medical device company developing a curvature changing fluid-optic intraocular lens (IOL) designed to restore continuous vision at all distances for individuals with cataracts and presbyopia by mimicking the eye's natural accommodation mechanism.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.